Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: Correlation with stage of disease and presence of opportunistic infection

Journal of Virology

Volumn 74, Issue 21, 2000, Pages 10256-10259

  Lawn, S D ^a   Butera, S T ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; PLASMA; PRIORITY JOURNAL; TUBERCULOSIS; VIREMIA; VIRUS ENVELOPE; VIRUS REPLICATION;

GENE PRODUCTS, ENV; HIV INFECTIONS; HIV-1; HLA-DR ANTIGENS; HUMAN; SUPPORT, NON-U.S. GOV'T; TUBERCULOSIS;

EID: 0033771053     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.21.10256-10259.2000     Document Type: Article

References (23)

1. Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus
2. Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions
3. The amount of HLA-DR proteins acquired by HIV-1 is virus strain and cell type specific
4. The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells
5. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity
6. HIV type 1 grown on interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells
7. Anti-class II antibodies in AIDS patients and AIDS-risk groups
8. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
9. Delay in the diagnosis of tuberculosis: A great new cost
10. Sustained plasma TNF-α and HIV-1 load despite resolution of other immune activation parameters during treatment of tuberculosis in Africans
11. Cellular compartments of HIV-1 replication: Determination by virion-associated host proteins and the impact of opportunistic infection in vivo
12. Correlation between HIV-1 RNA levels in the female genital tract and immune activation resulting from genital ulceration of the cervix
13. 2-microglobulin, respectively
14. Evidence for a superantigen in human tuberculosis
15. Host protein incorporation is conserved among diverse HIV-1 subtypes
16. HLA class II on HIV particles is functional in superantigen presentation to human T-cells: Implications for HIV pathogenesis
17. Detection of HLA-DR associated with monocytotropic, primary, and plasma isolates of human immunodeficieney virus type 1
18. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection
19. The effect of acute infectious illnesses on plasma human immunodeficiency virus type I load and the expression of serologic markers of immune activation among HIV-infected adults
20. The acquisition of host-encoded proteins by nascent HIV-1
21. Generalised immune activation in pulmonary tuberculosis: Coactivation with HIV infection
22. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders
23. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells